Abstract
The objective of this study was to compare the MALDI Biotyper system and the microbiological diagnosis algorithm for identification of non-fermenting bacteria isolated from respiratory tract in cystic fibrosis patients. The identification and typing algorithm, including bacteriologic, biochemical, and molecular methods as well as the MALDI Biotyper system was used. Using this algorithm, a total of 47 species of non-fermenting microorganisms was identified. The identification of microorganisms belonging to Achromobacter genus and Burkholderia cepacia complex (Bcc) proved to be the most difficult and require a combination of the methods listed above. Achromobacter species were isolated from 89 adults and children with cystic fibrosis, of which 82.7% and 10.6% belonged to Achromobacter ruhlandii and Achromobacter xylosoxidans, respectively. A total of 60 strains (3 species) of Bcc were isolated (32 strains – from adults and 28 strains – from children), of which 83.3% belonged to B. cenocepacia. The Bcc species were isolated from adult and pediatric patients with cystic fibrosis in Moscow (B. cenocepacia), Saint-Petersburg (B. contaminans, B. cepacia) and Khabarovsk (B. cepacia, B. cenocepacia, and B. contaminans). A total of 57 strains (11 species) of Pseudomonas spp. were isolated from adults and children, of which 41 strains (71.9%) were identified as P. aeruginosa (including 8 strains with atypical phenotype). P. aeruginosa proved to be an easier non-fermenting microorganism to be identified (except for isolates with atypical phenotype, where the use of MALDI-TOF mass spectrometry is critical).
National Research Center of Epidemiology and Microbiology named after N.F. Gamaleya, Moscow, Russia
National Research Center of Epidemiology and Microbiology named after N.F. Gamaleya, Moscow, Russia
National Research Center of Epidemiology and Microbiology named after N.F. Gamaleya, Moscow, Russia
I.M. Sechenov First Moscow State Medical University, Moscow, Russia
National Research Center of Epidemiology and Microbiology named after N.F. Gamaleya, Moscow, Russia
National Research Center of Epidemiology and Microbiology named after N.F. Gamaleya, Moscow, Russia
National Research Center of Epidemiology and Microbiology named after N.F. Gamaleya, Moscow, Russia
National Research Center of Epidemiology and Microbiology named after N.F. Gamaleya, Moscow, Russia
National Research Center of Epidemiology and Microbiology named after N.F. Gamaleya, Moscow, Russia
National Research Center of Epidemiology and Microbiology named after N.F. Gamaleya, Moscow, Russia
National Research Center of Epidemiology and Microbiology named after N.F. Gamaleya, Moscow, Russia
Research Centre of Medical Genetics, Moscow, Russia
Research Centre of Medical Genetics, Moscow, Russia
Research Centre of Medical Genetics, Moscow, Russia
Research Centre of Medical Genetics, Moscow, Russia
Research Centre of Medical Genetics, Moscow, Russia
Research Centre of Medical Genetics, Moscow, Russia
Research Institute of Pulmonology, Moscow, Russia
Research Institute of Pulmonology, Moscow, Russia
Research Institute of Pulmonology, Moscow, Russia
-
1.
Chernukha M.Yu., Avetisyan L.R., Shaginyan I.A., et al. Microbiological Diagnosis Algorithm for Chronic Lung Infection in Patients with Cystic Fibrosis. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2014;16(4):278-290. Russian.
-
2.
Anhalt J.P., Fenselau C. Identification of bacteria using mass spectrometry. Analyt Chem. 1975;500(2):219-225.
-
3.
Demidov E.A., Starostin K.V., Popik V.M., Peltek S.E. MALDI-Tof Mass Spectrometry in Microorganism Identification. Vavilovskij zhurnal genetiki i selekcii. 2013;17(4/1):758-764. Russian.
-
4.
Priputnevitch T.V., Melkumyan A.R., Burmenskaya O.V., et al. Use of MALDITOF Mass-Spectrometry and Quantitative PCR for Rapid Diagnosis of Sepsis. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2014;16(1):49. Russian.
-
5.
Patel R. MALDI-TOF MS for the Diagnosis of Infectious Diseases. Clin Chem. 2015;61(1):100-111.
-
6.
Bauernfeind A., Schneider I., Jungwirth R., Roller C. Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR. J Clin Microbiol. 1999;37(5):13351339.
-
7.
Mahenthiralingam E., Bischof J., Byrne S.K., et al. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis and Burkholderia cepacia genomovars I and III. J Clin Microbiol. 2000;38:3165-173.
-
8.
Lambiase A., Catania M.R., Del Pezzo M., et al. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis. 2011;30(8):973-980.
-
9.
List of Prokaryotic names with Standing in Nomenclature. Available at: www.bacterio.net/achromobacter.html.
-
10.
Voronina O.L., Kunda M.S., Ryzhova N.N., et al. Diversity and hazard of respiratory infection of Achromobacter spp. in cystic fibrosis patients. Pul'monologija. 2015;25(4):389-401. Russian.
-
11.
Krasovskii S.A., Nikonova V.S., Kashirskaya N.Y., et al. Clinical and Genetic, Microbiological and Functional Characteristics of Moscow and Moscow Region Patients with Cystic Fibrosis. Voprosy sovremennoj pediatrii. 2013;12(1):24-30. Russian.
-
12.
Sousa S.A., Ramos C.G., Leitão J.H. Burkholderia cepacia Complex: Emerging Multihost Pathogens Equipped with a Wide Range of Virulence Factors and Determinants. Int J Microbiol. 2011;2011. pii: 607575.
-
13.
Alexeeva G.V., Chernukha M.Yu., Shaginyan I.A. Identification of Burkholderia cepacia complex bacteria with PCR. In guidance manual for bacteriologists: Polymerase chain reaction (PCR) and its application in bacteriology. Moscow, 2006. 142 p. Russian.
-
14.
Voronina O.L., Kunda M.S., Aksenova E.I., et al. The express diagnostic of microorganisms affecting respiratory tract of patients with mucoviscidosis. Klinicheskaja laboratornaja diagnostika. 2013;11:53-58. Russian.
-
15.
Shaginyan I.A., Kapranov N.I., Chernukha M.Yu., et al. Microbial landscape of the lower respiratory tract in different age groups of children suffering from cystic fibrosis. Zhurnal mikrobiologii, jepidemiologii i immunobiologii. 2010;1:15-20. Russian.
-
16.
Chernukha M.Yu., Shaginyan I.A. Microbiology of chronic lung infection in patients with cystic fibrosis. In: Cystic fibrosis. M.: Medpraktika-M, 2014. 672 p. Russian.
-
17.
Wellinghausen N., Köthe J., Wirths B., Sigge A., Poppert S. Superiority of molecular techniques for identification of Gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis. J Clin Microbiol. 2005;43:4070-4075.